Mar

09

2026

Som tidigare meddelats har Hamlet BioPharma, tillsammans med det helägda dotterbolag Alpha1H BC AB (A1HB) och samarbetspartnern Linnane Pharma AB, und...

Mar

08

2026

Hamlet BioPharma AB (Hamlet), a clinical‑stage biopharmaceutical company advancing targeted oncological and other therapies, today announces that its ...

Feb

23

2026

Nature Microbiology publicerar banbrytande studie om icke-antibiotisk behandling av återkommande urinvägsinfektioner Hamlet BioPharma, det innovativa ...

Feb

18

2026

Catharina Svanborg featured in Global Digital Women’s Magazine Read the interview with Hamlet BioPharma’s founder Catharina Svanborg on Femest.com, p...

Feb

13

2026

  ...

Feb

12

2026

This groundbreaking study introduces an entirely new approach to managing recurrent urinary tract infections. Instead of killing the bacteria, the tre...

Feb

11

2026

Hamlet BioPharma invites you to our February investors’ meeting to be held on the 13th of February 2026, at 12:00. Please click on the link below to p...

Feb

03

2026

Hamlet BioPharma has signed an agreement with the Korean biotech company ImmunoForge, to develop novel administration technology for the peptide drug ...

Jan

27

2026

We warmly welcome you to the Symposium on “𝗡𝗼𝘃𝗲𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿.” The invited speakers are leading international scientists with...

Jan

16

2026

Welcome to Hamlet BioPharma’s monthly digital meeting on January 21 at 12:00, held the same day as the Davos Summit discusses ‘’The Fragile Future of ...